Yoshitaka Honma Selected Research

Yoshitaka Honma Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 05/2013
19	Stomach Neoplasms (Stomach Cancer) 01/2023 - 10/2013
19	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2012
16	Esophageal Squamous Cell Carcinoma 03/2024 - 12/2014
12	Carcinoma (Carcinomatosis) 04/2024 - 01/2016
11	Neoplasm Metastasis (Metastasis) 09/2020 - 08/2014
9	Disease Progression 11/2023 - 05/2014
7	Esophageal Neoplasms (Esophageal Cancer) 05/2024 - 12/2014
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 01/2017
7	Adenocarcinoma 03/2024 - 01/2012
5	Neuroendocrine Carcinoma 07/2023 - 09/2014
4	Squamous Cell Carcinoma of Head and Neck 10/2023 - 11/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 01/2018
3	Head and Neck Neoplasms (Head and Neck Cancer) 08/2023 - 01/2019
2	Lymphatic Metastasis 11/2023 - 01/2021
2	Sinonasal undifferentiated carcinoma 12/2022 - 03/2019
2	Malignant Mesothelioma 01/2022 - 12/2019
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2020
2	Ascites 12/2020 - 10/2013
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020 - 05/2016
2	Acneiform Eruptions 06/2020 - 01/2013
2	Hypertension (High Blood Pressure) 01/2020 - 01/2013
2	Diarrhea 10/2019 - 09/2016
2	Mucositis 10/2019 - 09/2016
2	Rectal Neoplasms (Rectal Cancer) 07/2019 - 05/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 09/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2023
1	Carcinogenesis 09/2023
1	Microsatellite Instability 09/2023
1	Angiomatoid Fibrous Histiocytoma 01/2022
1	Hypopharyngeal Neoplasms 10/2021
1	Papillomavirus Infections 02/2021

Drug/Important Bio-Agent (IBA)

16	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2013
12	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 10/2014
10	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 09/2012
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 09/2016
6	Docetaxel (Taxotere)FDA Link 03/2024 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
6	PlatinumIBA 04/2020 - 12/2014
5	Cetuximab (Erbitux)FDA Link 08/2023 - 01/2013
5	Panitumumab (Vectibix)FDA Link 01/2021 - 07/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 10/2013
5	Bevacizumab (Avastin)FDA Link 05/2017 - 01/2013
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2024 - 01/2017
4	NivolumabIBA 01/2023 - 01/2019
4	lanreotide (Somatuline)FDA Link 11/2021 - 01/2017
3	Everolimus FDA Link 12/2023 - 09/2020
3	Immune Checkpoint InhibitorsIBA 09/2023 - 10/2019
3	MicroRNAs (MicroRNA)IBA 07/2023 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 02/2021 - 05/2015
3	RamucirumabIBA 04/2020 - 07/2017
3	Formaldehyde (Formol)FDA Link 07/2014 - 05/2013
3	ParaffinIBA 07/2014 - 05/2013
2	Leucovorin (Folinic Acid)FDA Link 03/2024 - 05/2017
2	Etoposide (VP 16)FDA LinkGeneric 10/2022 - 01/2020
2	human ERBB2 proteinIBA 01/2022 - 02/2020
2	AndrogensIBA 01/2022 - 01/2021
2	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 06/2020 - 01/2013
2	Ointments (Pastes)IBA 06/2020 - 01/2013
2	taxaneIBA 02/2020 - 12/2014
2	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 11/2019
2	AlbuminsIBA 01/2020 - 05/2016
2	Capecitabine (Xeloda)FDA Link 03/2019 - 10/2014
2	Taxoids (Taxanes)IBA 07/2017 - 12/2014
2	LigandsIBA 08/2016 - 05/2015
2	Trastuzumab (Herceptin)FDA Link 01/2016 - 10/2014
2	AntibodiesIBA 01/2016 - 07/2014
2	Indicators and Reagents (Reagents)IBA 01/2016 - 04/2014
2	S-1 plus cisplatinIBA 10/2014 - 12/2013
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	Cytotoxins (Cytolysins)IBA 12/2023
1	Radioisotopes (Radionuclides)IBA 12/2023
1	Peptide Receptors (Peptide Receptor)IBA 12/2023
1	alpha Catenin (alpha E-Catenin)IBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 11/2023
1	alectinibIBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 09/2023
1	Epidermal Growth Factor (EGF)IBA 08/2023
1	SodiumIBA 08/2023
1	RNA (Ribonucleic Acid)IBA 08/2023
1	Keratins (Keratin)IBA 01/2022
1	Calbindin 2IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2021
1	2- oxo- 1,2,3,6- tetrahydropyrimidine- 4,6- dicarboxylateIBA 01/2021

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 03/2024 - 01/2012
29	Therapeutics 05/2024 - 09/2012
16	Chemoradiotherapy 03/2024 - 05/2016
7	Radiotherapy 10/2023 - 03/2019
5	Induction Chemotherapy 12/2022 - 07/2016
4	Neoadjuvant Therapy 05/2024 - 08/2018
3	Esophagectomy 01/2023 - 01/2017
3	Combination Drug Therapy (Combination Chemotherapy) 05/2018 - 10/2014
2	Immunotherapy 09/2023 - 01/2019
2	Brachytherapy 12/2022 - 10/2021
1	Contraindications 12/2023
1	Neck Dissection (Radical Neck Dissection) 11/2023
1	Pharyngectomy 10/2023
1	Salvage Therapy 01/2021